StrideBio, LLC

StrideBio, LLC

StrideBio, LLC

StrideBio, LLC is a gene therapy company focused on creating and developing novel adenoassociated viral (AAV) vector technologies and therapeutics for rare diseases.
Type
B2b
Founded
2015
Raised
$15.7M
Follow us
Alexa global traffic share
Latest funding
Undisclosed amount
Seed fund - 2017
Hatteras Venture Partners
Team Size
2
Employees
$15,700,000 Venture capital (Series A)
Venture Funding News , PE HUB

StrideBio Closes $15.7M Series A

FinSMEs

StrideBio Closes $15.7M in Series A Financing

Funding